Hiroki Ashida, Ph.D, is the Vice President of Eight Roads Ventures, a global VC firm with more than $10B in AUM and over 50 years of history. Hiroki helped establish their biotech investment practice in Japan seven years ago and covers all biotech and therapeutics deals. He works closely with their sister fund F-Prime Capital Partners in the US and other Eight Roads global teams around the world to invest both domestically and globally, leveraging the science and technologies from Japan. Hiroki aims to become a bridge between the global and Japanese markets. 

​

Prior to joining Eight Roads, Hiroki worked as a management consultant at Accenture Strategy and holds a Ph.D. in computational biology from the University of Tokyo where he conducted research on epigenetics and ncRNAs.